PMID- 21844921 OWN - NLM STAT- MEDLINE DCOM- 20120216 LR - 20220317 IS - 1572-0241 (Electronic) IS - 0002-9270 (Linking) VI - 106 IP - 12 DP - 2011 Dec TI - Esophageal acid exposure decreases intraluminal baseline impedance levels. PG - 2093-7 LID - 10.1038/ajg.2011.276 [doi] AB - OBJECTIVES: Intraluminal baseline impedance levels are determined by the conductivity of the esophageal wall and can be decreased in gastroesophageal reflux disease (GERD) patients. The aim of this study was to investigate the baseline impedance in GERD patients, on and off proton pump inhibitor (PPI), and in healthy controls. METHODS: Ambulatory 24-h pH-impedance monitoring was performed in (i) 24 GERD patients with and 24 without pathological esophageal acid exposure as well as in 10 healthy controls and in (ii) 20 patients with refractory GERD symptoms despite PPI, once on PPI and once off PPI. Baseline impedance levels in the most distal and the most proximal impedance channels were assessed. RESULTS: Median (interquartile range) distal baseline impedance in patients with physiological (2,090 (1,537-2,547) Omega) and pathological (781 (612-1,137) Omega) acid exposure was lower than in controls (2,827 (2,127-3,270) Omega, P<0.05 and P<0.001). A negative correlation between 24-h acid exposure time and baseline impedance was observed (r=-0.7, P<0.001). In patients measured off and on PPI, median distal baseline impedance off PPI was significantly lower than on PPI (886 (716-1,354) vs. 1,372 (961-1,955) Omega, P<0.05) and distal baseline impedance in these groups was significantly lower than in healthy controls (P<0.05 and P<0.001). Proximal baseline impedance did not differ significantly between the patients off PPI and on PPI (1,793 (1,384-2,489) vs. 1,893 (1,610-2,561) Omega); however, baseline impedance values in both measurements were significantly lower than in healthy controls (3,648 (2,815-3,932) Omega, both P<0.001). CONCLUSIONS: These findings suggest that baseline impedance is related to esophageal acid exposure and could be a marker of reflux-induced changes to the esophageal mucosa. FAU - Kessing, Boudewijn F AU - Kessing BF AD - Department of Gastroenterology and Hepatology, Academic Medical Center Amsterdam, The Netherlands. b.f.kessing@amc.uva.nl FAU - Bredenoord, Albert J AU - Bredenoord AJ FAU - Weijenborg, Pim W AU - Weijenborg PW FAU - Hemmink, Gerrit J M AU - Hemmink GJ FAU - Loots, Clara M AU - Loots CM FAU - Smout, A J P M AU - Smout AJ LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20110816 PL - United States TA - Am J Gastroenterol JT - The American journal of gastroenterology JID - 0421030 RN - 0 (Proton Pump Inhibitors) SB - IM CIN - Am J Gastroenterol. 2012 Jul;107(7):1104; author reply 1104-5. PMID: 22764027 MH - Adult MH - Aged MH - Case-Control Studies MH - Drug Resistance MH - Electric Conductivity MH - Electric Impedance MH - *Esophageal pH Monitoring MH - Esophagus/*metabolism MH - Female MH - Gastric Acid/*metabolism MH - Gastroesophageal Reflux/*metabolism MH - Humans MH - Male MH - Middle Aged MH - Proton Pump Inhibitors/*therapeutic use MH - Young Adult EDAT- 2011/08/17 06:00 MHDA- 2012/02/18 06:00 CRDT- 2011/08/17 06:00 PHST- 2011/08/17 06:00 [entrez] PHST- 2011/08/17 06:00 [pubmed] PHST- 2012/02/18 06:00 [medline] AID - ajg2011276 [pii] AID - 10.1038/ajg.2011.276 [doi] PST - ppublish SO - Am J Gastroenterol. 2011 Dec;106(12):2093-7. doi: 10.1038/ajg.2011.276. Epub 2011 Aug 16.